20952 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Growth factors; Growth regulators Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
Mesenchymal stem cells for the treatment of CNS diseases
#302BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#303Methods and compositions for inducing differentiation of human brown adipocyte progenitors
#304Use of encapsulated cell therapy for treatment of ophthalmic disorders
#305COMPOSITIONS AND METHODS FOR TREATMENT OF EXERCISE-INDUCED PULMONARY HEMORRHAGE OR NASOPHARYNGEAL CICATRIX
#306GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS
#307TREATMENT OF A NEURODEGENERATIVE DISEASE OR DISORDER
#308Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms
#309Compositions and methods for modulating neuronal excitability and motor behavior
#310Auris formulations for treating otic diseases and conditions
#311METHODS AND COMPOSITIONS FOR TREATING BONE DISEASES
#312METHODS FOR TREATMENT OF MICROCEPHALY ASSOCIATED AUTISM DISORDERS
#313Methods of delivering pharmaceutical agents
#314Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
#315Modulation of axon degeneration
#316Combination therapies for the treatment of Alzheimer's disease and related disorders
#317Combination therapies for the treatment of alzheimer's disease and related disorders
#318Treatment of autism spectrum disorders with ciliary neurotrophic factor peptide mimetic
#319Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions
#320Method and apparatus for close-field electroporation
#321Auris formulations for treating otic diseases and conditions
#322NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE
#323Therapeutic use of a growth factor, METRNL
#324COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY
#325METHODS FOR REDUCING ACUTE AXONAL INJURY
#326Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
#327Methods of treating neurodegenerative conditions
#328Method and composition for hyperthermally treating cells
#329Methods for promoting wound healing and hair growth comprising GDNF administration
#330GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS
#331GLYPISOME AS AN ENHANCER OF ANGIOGENIC GROWTH FACTOR ACTIVITY
#332Cell lines and their use in encapsulated cell biodelivery
#333Administration of growth factors for the treatment of CNS disorders
#334Method of preparing an implantable neuroendoprosthetic system
#335Solvent/polymer solutions as suspension vehicles
#336Combination therapies for the treatment of Alzheimer's disease and related disorders
#337Methods of delivering pharmaceutical agents
#338Method and composition for hyperthermally treating cells
#339Treatment of brain injury with a neurotrophic peptide
#340BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#341Method and system for treatment of cardiovascular disorders
#342Method and system for treatment of cardiovascular disorders
#343Method and system for treatment of cardiovascular disorders
#344Urine stem cells for skeletal muscle generation and uses thereof
#345Treatment of allodynia
#346Nerve regeneration employing keratin biomaterials
#347Compounds and methods for modulating pharmacokinetics
#348AAV-mediated gene therapy for RPGR X-linked retinal degeneration
#349Neurturin molecules
#350Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
#351Soluble MANF in pancreatic β-cell disorders
#352Compositions and methods for treatment of cardiovascular disorders
#353Microparticles supporting cells and active substances
#354Systems and methods for angiogenic treatment in wound healing
#355Compositions and Methods for Preventing and/or Treating Sensorineural Hearing Loss
#356Neurturin molecules
#357Administration of angiocidin for arresting the growth of a tumor cell
#358BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF
#359Mesenchymal stem cells for the treatment of CNS diseases
#360CONCENTRATED PROTEIN PREPARATIONS OF BONE MORPHOGENETIC PROTEINS AND METHODS OF USE THEREOF
#361SCAFFOLD FOR ENHANCED NEURAL TISSUE REGENERATION
#362ENGINEERED PEPTIDE (EP)-DIRECTED PROTEIN INTERCELLULAR DELIVERY SYSTEM AND USES THEREOF
#363Neurotrophic factor MANF and uses thereof
#364Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors
#365USE OF BETA-NERVE GROWTH FACTOR FOR INDUCING OVULATION IN MAMMALS
#366Composition for controlled release of physiologically active substance
#367Cell lines and their use in encapsulated cell biodelivery
#368TREATMENT USING NEUBLASTIN POLYPEPTIDES
#369Reverse thermal gels and their use in cell therapy
#370Locally released growth factors to mediate motor recovery after stroke
#371Methods for use of neural stem cell compositions for treatment of central nervous system lesions
#372COMPOSITIONS AND METHODS FOR DENTAL TISSUE REGENERATION
#373Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders
#374METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURIN
#375Peptides that target dorsal root ganglion neurons
#376Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disorders
#377Adeno-associated virus virions with variant capsid and methods of use thereof
#378Topical preparation containing NGF for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo
#379Method for treating chemotherapy-induced male infertility
#380ADHESIVE CELL TISSUE GELS
#381Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#382FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS
#383Enhancing a population of insulin releasing cells using GFR α-1 agonists
#384Mesenchymal stem cells for the treatment of CNS diseases
#385Method and system for treatment of cardiovascular disorders
#386Methods for therapy of neurodegenerative disease of the brain
#387METHODS AND COMPOSITIONS FOR THE "BROWNING" OF WHITE FAT
#388GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR, OBESITY, AND OBESITY-RELATED DISEASES AND CONDITIONS
#389Administration of growth factors for the treatment of CNS disorders
#390Methods for treating nervous system injury and disease
#391Variants of human GDNF
#392COMPOUNDS AND METHODS
#393Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
#394NEURTURIN MOLECULES
#395Sustained drug delivery system
#396Compositions and methods for increasing vascularization
#397Administration of SNS Neuroprotective Agents to Promote Hematopoietic Regeneration
#398Adeno-associated virus vector for gene transfer to nervous system cells
#399Implantable medical devices having double walled microspheres
#400METHOD OF TREATING PAIN BY ADMINISTRATION OF NERVE GROWTH FACTOR
#401System and method for treatment of hemorrhagic stroke
#402TREATMENT USING NEUBLASTIN POLYPEPTIDES
#403PHARMACEUTICAL COMPOSITION FOR PROMOTING ARTERIOGENESIS, AND PREPARATION METHOD AND APPLICATIONS FOR THE SAME
#404Dopaminergic neuronal survival-promoting factors and uses thereof
#405Amidated dopamine neuron stimulating peptide restoration of mitochondrial activity
#406COSMETIC AND DERMATOLOGICAL FORMULATIONS OF MNTF PEPTIDES
#407Solvent/polymer solutions as suspension vehicles
#408Solvent/polymer solutions as suspension vehicles
#409Methods of delivering pharmaceutical agents
#410Regeneration and repair of neural tissue using postpartum-derived cells
#411ADHESIVE CELL TISSUE GELS
#412Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein
#413Methods for promoting the revascularization and reenervation of CNS lesions
#414Solvent/polymer solutions as suspension vehicles
#415Methods of treating chronic simple glaucoma with ophthalmic preparations based on BDNF (brain-derived neurotrophic factor)
#416Methods for treating nervous system injury and disease
#417Glycopegylation methods and proteins/peptides produced by the methods
#418Brain-derived neurotrophic factor or neurotrophin-4/5 to treat periodontal diseases and pulpal diseases
#419Composition and Method for the Treatment or Prevention of Spinal Disorders III
#420TRANSPLANTATION OF BONE MARROW STROMAL CELLS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
#421THERAPEUTIC USE OF A GROWTH FACTOR, NSG33
#422Variants of pigment epithelium derived factor and uses thereof
#423Sustained drug delivery system
#424Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
#425Adeno-associated virus virions with variant capsid and methods of use thereof
#426Method for treating damaged tissue of the CNS
#427Method of treating intraoccular tissue pathologies with nerve growth factor
#428DIAGNOSTIC AGENT FOR ISCHEMIC HEART DISEASE RISK GROUP
#429Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
#430TREATMENT USING NEUBLASTIN POLYPEPTIDES
#431METHODS FOR TREATING PARKINSON'S DISEASE AND OTHER DISORDERS OF DOPAMINERGIC NEURONS OF THE BRAIN
#432Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
#433Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#434Cell lines and their use in encapsulated cell biodelivery
#435Mesenchymal stem cells for the treatment of CNS diseases
#436Administration of growth factors for the treatment of CNS disorders
#437BONE MORPHOGENETIC PROTEIN COMPOSITIONS
#438Administration of angiocidin for the treatment of leukemia
#439Methods of treating stroke using stem cell-like menstrual blood cells
#440Solvent/polymer solutions as suspension vehicles
#441Modulation of axon degeneration
#442Method for treating diabetes using neurturin
#443Method of treating parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen
#444Micronized device for the delivery of biologically active molecules and methods of use thereof
#445TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1 PEPTIDES OR ANALOGS THEREOF
#446METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
#447NEURODEGENERATIVE DISORDERS
#448Peptides that target dorsal root ganglion neurons
#449IMPLANTABLE NEUROENDOPROSTHETIC SYSTEM, A METHOD OF PRODUCTION THEREOF AND A METHOD OF RECONSTRUCTIVE NEUROSURGICAL OPERATION
#450Nerve regeneration employing keratin biomaterials
#451SOCS3 Inhibition Promotes CNS Neuron Regeneration
#452GRAFT COMPOSITION FOR NEURAL TISSUE REGENERATION, METHOD OF PRODUCTION AND USES THEREOF
#453Therapeutic use of a growth factor, METRNL
#454METHODS FOR PROMOTING STEM CELL PROLIFERATION AND SURVIVAL
#455METHOD OF UPREGULATING SORLA FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#456Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
#457COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM
#458Methods for treating neurological deficits
#459USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS
#460Controlled release multidrug formulations for spinal cord injury
#461Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
#462Enhanced ocular neuroprotection and neurostimulation
#463METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE
#464CXCL12 GAMMA A CHEMOKINE AND USES THEREOF
#465APHERESIS, ADMINISTRATION OF AGENT, OR COMBINATION THEREOF
#466Neurturin conjugates for pharmaceutical use
#467INJECTION VEHICLE FOR POLYMER-BASED FORMULATIONS
#468Splice variants of GDNF and uses thereof
#469Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
#470SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#471Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
#472Methods for increasing vascularization
#473Regeneration and repair of neural tissue using postpartum-derived cells
#474ACTIVE SOLUBLE POST-TRANSLATIONALLY MODIFIED NEUREGULIN ISOFORMS
#475Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands
#476Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
#477Tissue Regeneration II
#478Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#479Therapeutic hybrid implantable devices
#480Complex consisted of a polysaccharide and an HBP
#481Pantropic neurotrophic factors
#482ACTIVE OR PASSIVE IMMUNIZATION AGAINST PROAPOPTOTIC NEUROTROPHINS FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES
#483Muller Cell Specific Gene Therapy
#484Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
#485Methods and compositions for treatment of ocular neovascularization and neural injury
#486Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene
#487Dopaminergic neuronal survival-promoting factors and uses thereof
#488Method of treating cravings by administration of nerve growth factor
#489TrkB Agonists for Treating Autoimmune Disorders
#490COMPOSITIONS AND METHODS FOR ADMINISTERING GDNF LIGAND FAMILY PROTEINS
#491Glycopegylation methods and proteins/peptides produced by the methods
#492CELL IMPLANTATION TO PREVENT AND/OR TREAT HEARING LOSS
#493Bone Morphogenetic Protein Compositions
#494Electrical stimulation method for treatment of peripheral neuropathy
#495Methods for therapy of neurodegenerative disease of the brain
#496Auris formulations for treating otic diseases and conditions
#497METHOD OF MODULATION OF MULLERIAN INHIBITORY SUBSTANCE (MIS) RECEPTOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#498Trophic factor combinations for nervous system treatment
#499METHODS FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST
#500Compositions for the prevention and treatment of neuroinjury and methods of use thereof
#501Neurotrophic factor MANF and uses thereof
#502Cosmetic and dermatological formulations of MNTF peptides
#503Variants of pigment epithelium derived factor and uses thereof
#504TREATMENT USING NEUBLASTIN POLYPEPTIDES
#505Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
#506METHODS OF TREATING OBESITY OR DIABETES USING NT-4/5
#507Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein
#508FIBRIN GLUE COMPOSITION FOR REPAIRING NERVE DAMAGE AND METHODS THEREOF
#509METHODS OF TREATING ALZHEIMER'S DISEASE
#510Fusion proteins for delivery of GDNF to the CNS
#511ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#512USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMER'S AND PARKINSON'S DISEASE
#513Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#514METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MALE ERECTILE DYSFUNCTION AND FEMALE SEXUAL AROUSAL DISORDER
#515METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE DISEASE
#516METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF PATIENTS WITH AUTOANTIBODY POSITIVE DISEASE
#517Therapeutic angiogenesis for treatment of the spine
#518DEVICE AND METHOD FOR CELL GRAFTING
#519Methods of treating neuronal disorders using MNTF peptides and analogs thereof
#520Method of Treating Parkinson's Disease in Humans by Direct Infusion of Glial Cell-Line Derived Neurotrophic Factor Into the Zona Incerta
#521Methods of inducing tubulogenesis and/or branching morphogenesis of kidney cell cultures
#522Topographical Templating of Polymeric Materials Using Cellular Morphology
#523Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
#524Human Therapeutic Cells Secreting Nerve Growth Factor
#525Methods for treating nervous system injury and disease
#526Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Gdnf
#527Method for Treating Neurological Disorders
#528Method of inducing and maintaining neuronal cells
#529Treatment of Retinopathies Using Gfra3 Agonists
#530Method for Preventing and Treating Diabetes Using Neurturin
#531Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF)
#532Synapse-specific proteins in glomeruli
#533Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#534Use of cyclosporin A to sensitize resistant cancer cells to death receptor ligands
#535Orally active peptides that prevent cell damage and death
#536Compositions and methods for therapy or prevention of chemotherapy-induced neuropathy
#537Enhancing a population of insulin releasing cells using GFR-A1 agonists
#538Methods and compositions for treatment of ocular neovascularization and neural injury
#539METHOD FOR INDUCING NEURAL DIFFERENTIATION
#540DEVICES CONTAINING DNA ENCODING NEUROTROPHIC AGENTS AND RELATED COMPOSITIONS AND METHODS
#541Diagnostic Agent For Ischemic Heart Disease Risk Group
#542COMPOSITION AND METHOD FOR PRODUCING COMPOSITION FOR CONSTRUCTING TISSUE, AND TISSUE CONSTRUCT
#543Selective induction of apoptosis to treat ocular disease by expression of PEDF
#544MODULATION OF POLYSIALYLATED NEURAL ADHESION MOLECULES (PSA-NCAM) AS A REGULATOR OF OCULAR DISEASE
#545Vector system
#546ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION
#547Fibrin glue composition for repairing nerve damage and methods thereof
#548ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#549Method for detecting candidate alzheimer's disease drug
#550Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
#551Methods and systems for neural maintenance and regeneration
#552Neublastin variants
#553Trojan horse immunotherapy
#554Methods and systems for neural maintenance and regeneration
#555Method for inhibiting apoptosis through the p75 neurotrophin receptor
#556Methods and systems for neural maintenance and regeneration
#557Methods and systems for neural maintenance and regeneration
#558Methods and systems for neural maintenance and regeneration
#559Nerve regeneration employing keratin biomaterials
#560Therapeutic use of a growth factor, NsG33
#561Methods of Treating Constipation by Administration of Nerve Growth Factor
#562TREATMENT OF A WOUND WITH A VASODILATOR
#563Administration of growth factors for the treatment of CNS disorders
#564Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
#565Methods for therapy of neurodegenerative disease of the brain
#566METHODS WANTED FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONIST
#567REMEDIES FOR NERVE DAMAGES
#568Nonexpansion Protocol for Autologous Cell-Based Therapies
#569Topical Treatment with NGF and DHA in Damaged Corneas
#570Trophic factor combinations for nervous system treatment
#571Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration
#572Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient
#573Medicines containing nerve growth factor for assisting losing weight and methods for assisting losing weight using same
#574Micronized device for the delivery of biologically active molecules and methods of use thereof
#575Method for regulating neuron development and maintenance
#576Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands
#577Method of modulating fertility in animals
#578Injection vehicle for polymer-based formulations
#579Methods and compositions for use in treatment of patients with autoantibody positive disease
#580VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
#581Enhanced ocular neuroprotection and neurostimulation
#582Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
#583Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics
#584Methods for therapy of neurodegenerative disease of the brain
#585Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#586Glycopegylation methods and proteins/peptides produced by the methods
#587Biommetic hierarchies using functionalized nanoparticles as building blocks
#588Enhanced ocular neuroprotection and neurostimulation
#589Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#590Enhanced recovery following ocular surgery
#591Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#592Methods for elevating neurotrophic agents
#593Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases
#594Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
#595Pantropic neurothrophic factors
#596Co-grafts for treating Parkinson's disease
#597Repair and regeneration of ocular tissue using postpartum-derived cells
#598Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
#599Compositions and regime/regimen for treating the adverse signs of cutaneous skin aging
#600Novel neurotrophic factor protein and uses thereof